Recently, ASCL1 was shown to be capable of reorganizing and promoting the accessibility of closed chromatin in embryonic stem cells, neural progenitors, as well as glioma cell lines (Casey, Kollipara, Pozo, & Johnson, 2018; Park et al., 2017; Raposo et al., 2015). Here, ASCL1 is linked to central nervous system cancer.